Neil Gagnon purchases 38,117 shares @ $4.52 per share for a total of $172,424.
|
COMPANY INFORMATION
|
||
|
APEN by TradingView
|
Company Info:
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
|
LATEST INSIDER ACTIVITY
|
||
|
INSIDER:
Neil Gagnon
SHARES BOUGHT:
38,117
PURCHASE DATE:
2/03/2021 |
TITLE:
10% Shareholder
% INCREASE:
2%
FILE DATE:
2/05/2021
|
|
|
INSIDER PURCHASE PRICE
$4.52
|
||
Insider Notes:
Gagnon Neil Purchase 11,346 shares @ $4.41 totaling $50,046
|
ANALYST RECOMMENDATION
|
||
|
TARGET PRICE:
$7.00 TARGET GAIN:
55% |
AVERAGE RATING:
BUY ANALYST COVERING:
2 |
|
| IMPORTANT DISCLOSURE | ||
|
TECHNICAL ANALYSIS
|
||
|
|
|
|